
Investments
18
Want to inform investors similar to Gates Frontier about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Gates Frontier News
Sep 19, 2023
Nimbus Therapeutics, a clinical-stage company that designs and develops breakthrough medicines through its powerful computational drug discovery engine, announced the closing of a $210 million private financing to advance its next wave of tech-enabled small molecule medicines. The round was co-led by new investor GV (Google Ventures) and existing investors SR One and Atlas Venture, with participation from another new investor that is a U.S.-based life sciences-focused fund as well as existing investors Bain Capital Life Sciences, BVF Partners L.P., Gates Frontier, Lightstone Ventures, Pfizer Ventures, RA Capital Management, and SV Health Investors. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Gates Frontier Investments
18 Investments
Gates Frontier has made 18 investments. Their latest investment was in Peregrine Hydrogen as part of their Seed VC on September 9, 2023.

Gates Frontier Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
9/22/2023 | Seed VC | Peregrine Hydrogen | $7.8M | Yes | 2 | |
9/6/2023 | Series G | Nimbus Therapeutics | $210M | Yes | 2 | |
8/17/2023 | Series D | Pivotal Commware | $102M | Yes | 4 | |
6/29/2023 | Series B | |||||
4/27/2023 | Seed VC |
Date | 9/22/2023 | 9/6/2023 | 8/17/2023 | 6/29/2023 | 4/27/2023 |
---|---|---|---|---|---|
Round | Seed VC | Series G | Series D | Series B | Seed VC |
Company | Peregrine Hydrogen | Nimbus Therapeutics | Pivotal Commware | ||
Amount | $7.8M | $210M | $102M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 2 | 4 |